$TARS Tarsus Pharmaceuticals, Inc. Insider Trading Week 42/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tarsus Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Tarsus Pharmaceuticals, Inc. in week 42/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Option Exercise | C | 0.00 | 214,281 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,390,376 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 1,917,157 | 1.6 M to 1.9 M (+19.47 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | C | 0.00 | 214,281 | 0 | 1,604,657 | 1.4 M to 1.6 M (+15.41 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | C | 0.00 | 1,390,376 | 0 | 1,390,376 | 0 to 1.4 M |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 71,427 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 245,966 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 1,434,790 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 3,698 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | C | 0.00 | 21,575 | 0 | 0 | |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | P | 16.00 | 168,750 | 2,700,000 | 1,920,933 | 1.8 M to 1.9 M (+9.63 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 71,427 | 0 | 1,752,183 | 1.7 M to 1.8 M (+4.25 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 245,966 | 0 | 1,680,756 | 1.4 M to 1.7 M (+17.14 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 1,434,790 | 0 | 1,434,790 | 0 to 1.4 M |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | P | 16.00 | 3,125 | 50,000 | 28,398 | 25.3 K to 28.4 K (+12.36 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 3,698 | 0 | 25,273 | 21.6 K to 25.3 K (+17.14 %) |
| Oct 20 2020 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Buy | C | 0.00 | 21,575 | 0 | 21,575 | 0 to 21.6 K |